Implementación de la estrategia basal plus en la práctica clínica
- Agustín Angel Merchante Alfaro
- Francisco Javier García Soidán
- Fernando Álvarez Guisasola
- J.L. Bianchi Llave
- F. Carral San Laureano
- P. Checa
- Fernando Losada Viñau
- A. Marco
- María Antonia Pérez Lázaro
- Manuel Pérez Maraver
- Alfredo Yoldi Arrieta
- Carles Zafón Llopis
- Francisco Javier Ampudia
ISSN: 1134-3230
Ano de publicación: 2010
Volume: 26
Número: 5
Páxinas: 339-346
Tipo: Artigo
Outras publicacións en: Avances en diabetología
Obxectivos de Desenvolvemento Sustentable
Resumo
Insulin treatment may be necessary in type 2 diabetes, because many patients are not able over the time to achieve or maintain glycemic targets to prevent chronic complications associated to sustained hyperglycemia. Initially, addition of basal insulin to previous treatment with oral agents is the most commonly used regimen. This strategy is based on optimal control of fasting plasma glucose. However, a significant proportion of patients does not achieve or maintain HbA1c target ≤7%, because they show excessive postprandial glucose values. Therefore, the next step for intensification of treatment might be the addition of a single dose of prandial insulin before the main meal, which is associated with the greatest postprandial glucose excursion (basal plus strategy), maintaining previous treatment with basal insulin and oral agents. This regimen has demonstrated to be easy to use, effective and appropriate for many patients. Furthermore, if necessary, it makes easier progressive introduction of additional injections of prandial insulin until the basal bolus strategy. In this manuscript, recommendations from a multidisciplinary working group are summarized for an adequate implementation of the basal plus strategy in the routine clinical practice.